Evofem Biosciences, Inc. (NASDAQ:EVFM – Get Free Report)’s stock price crossed below its 50 day moving average during trading on Monday. The stock has a 50 day moving average of $0.01 and traded as low as $0.0074. Evofem Biosciences shares last traded at $0.0074, with a volume of 126,739 shares changing hands.
Evofem Biosciences Price Performance
The stock has a market cap of $980,722.00, a P/E ratio of -0.01 and a beta of -1.30. The firm’s fifty day moving average price is $0.01 and its two-hundred day moving average price is $0.01.
Evofem Biosciences Company Profile
Evofem Biosciences, Inc was a biopharmaceutical company focused on developing and commercializing products for women’s sexual and reproductive health. Its lead product was Phexxi, a non-hormonal, on-demand prescription vaginal gel designed to prevent pregnancy by maintaining an acidic vaginal environment that reduces sperm motility.
Phexxi received approval from the U.S. Food and Drug Administration in 2020 and was marketed in the United States. The product was positioned as a hormone-free contraceptive option that could be used immediately before or shortly after sexual intercourse.
Further Reading
- Five stocks we like better than Evofem Biosciences
- Deutsche Bank Makes a Contrarian Call on Netflix—What Does It Mean for Investors?
- O’Reilly Automotive’s Stock Slump Hides a Stronger Business
- McDonald’s Stock Slump Makes Its AI Pricing Bet Even Riskier
- Broadcom’s AI Growth Story Faces a $161 Billion Anthropic Test
Receive News & Ratings for Evofem Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evofem Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
